A series of novel 3-alkyl-1,5-diaryl-1H-pyrazoles were synthesized as combretastatin A-4 (CA-4) analogues and evaluated for antiproliferative activity against three human cancer cell lines (SGC-7901, A549 and HT-1080). Most of the target compounds displayed moderate to potent antiproliferative activity, and 7k was found to be the most potent compound. Structure-activity relationships indicated that compounds with a trimethoxyphenyl A-ring at the N-1 position of the pyrazole skeleton were more potent than those with the A-ring at the C-5 position. Tubulin polymerization and immunostaining experiments revealed that 7k potently inhibited tubulin polymerization and disrupted tubulin microtubule dynamics in a manner similar to CA-4. Computationa...
Three different series of cis-restricted analogues of combretastatin A-4 (CA-4), corresponding to th...
ABSTRACT: A series of novel pyridine-bridged analogues of combretastatin-A4 (CA-4) were designed and...
Cancer is the second most common cause of death in the USA. Among the known classes of anticancer ag...
<div><p>A series of novel 3-alkyl-1,5-diaryl-1<i>H</i>-pyrazoles were synthesized as combretastatin ...
A series of novel 3-alkyl-1,5-diaryl-1H-pyrazoles were synthesized as combretastatin A-4 (CA-4) anal...
A series of 3-(3′,4′,5′-trimethoxyphenyl)-4-substituted 1H-pyrazole and their related 3-aryl-4-(3′,4...
Twenty-three combretastatin A-4 (CA-4) analogues were synthesized by judiciously incorporating a fun...
<p>(A) tubulin is displayed as a flat ribbon with <i>α</i>-tubulin coloured lavender and <i>β</i>-tu...
Tubulin, the major structural component of microtubules, is a target for the development of anticanc...
Tubulin, the major structural component of microtubules, is a target for the development of antican...
A series of pyrazoline bridged combretastatin analogues were designed and synthesised from their pre...
Fourteen N-acetylated and non-acetylated 3,4,5-tri- or 2,5-dimethoxypyrazoline analogs of combretast...
Cancer is the second most common cause of death in the USA. Among the known classes of anticancer ag...
Three different series of cis-restricted analogues of combretastatin A-4 (CA-4), corresponding to th...
Twenty-three combretastatin A-4 (CA-4) analogues were synthesized by judiciously incorporating a fun...
Three different series of cis-restricted analogues of combretastatin A-4 (CA-4), corresponding to th...
ABSTRACT: A series of novel pyridine-bridged analogues of combretastatin-A4 (CA-4) were designed and...
Cancer is the second most common cause of death in the USA. Among the known classes of anticancer ag...
<div><p>A series of novel 3-alkyl-1,5-diaryl-1<i>H</i>-pyrazoles were synthesized as combretastatin ...
A series of novel 3-alkyl-1,5-diaryl-1H-pyrazoles were synthesized as combretastatin A-4 (CA-4) anal...
A series of 3-(3′,4′,5′-trimethoxyphenyl)-4-substituted 1H-pyrazole and their related 3-aryl-4-(3′,4...
Twenty-three combretastatin A-4 (CA-4) analogues were synthesized by judiciously incorporating a fun...
<p>(A) tubulin is displayed as a flat ribbon with <i>α</i>-tubulin coloured lavender and <i>β</i>-tu...
Tubulin, the major structural component of microtubules, is a target for the development of anticanc...
Tubulin, the major structural component of microtubules, is a target for the development of antican...
A series of pyrazoline bridged combretastatin analogues were designed and synthesised from their pre...
Fourteen N-acetylated and non-acetylated 3,4,5-tri- or 2,5-dimethoxypyrazoline analogs of combretast...
Cancer is the second most common cause of death in the USA. Among the known classes of anticancer ag...
Three different series of cis-restricted analogues of combretastatin A-4 (CA-4), corresponding to th...
Twenty-three combretastatin A-4 (CA-4) analogues were synthesized by judiciously incorporating a fun...
Three different series of cis-restricted analogues of combretastatin A-4 (CA-4), corresponding to th...
ABSTRACT: A series of novel pyridine-bridged analogues of combretastatin-A4 (CA-4) were designed and...
Cancer is the second most common cause of death in the USA. Among the known classes of anticancer ag...